Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion

Patients with chronic lymphocytic leukemia (CLL) or monoclonal B-lymphocytosis (MBL) have impaired response to COVID-19 vaccination. A total of 258 patients (215 with CLL and 43 with MBL) had antispike antibody levels evaluable for statistical analysis. The overall seroconversion rate in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yandong, Freeman, Jane A., Holland, Juliette, Naidu, Kartik, Solterbeck, Ann, Van Bilsen, Nenna, Downe, Paul, Kerridge, Ian, Wallman, Lucinda, Akerman, Anouschka, Aggarwal, Anupriya, Milogiannakis, Vanessa, Martins Costa Gomes, Gabriela, Doyle, Chloe M., Sandgren, Kerrie J., Turville, Stuart, Cunningham, Anthony L., Mulligan, Stephen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by The American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550283/
https://www.ncbi.nlm.nih.gov/pubmed/36206503
http://dx.doi.org/10.1182/blood.2022017814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550283/
https://www.ncbi.nlm.nih.gov/pubmed/36206503
http://dx.doi.org/10.1182/blood.2022017814

Ejemplares similares